Evidence-based emergency medicine: Updates, feedback, and links

Annals of Emergency Medicine

Volumn 34, Issue 5, 1999, Pages 657-663

  Wyer, P C ^a   Cordell, W H ^a  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

CEREBROVASCULAR ACCIDENT; DRUG EFFICACY; DRUG SAFETY; EMERGENCY MEDICINE; EVIDENCE BASED MEDICINE; FIBRINOLYTIC THERAPY; HUMAN; MEDICAL RESEARCH; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SHORT SURVEY;

EID: 0032753351     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-0644(99)70168-X     Document Type: Article

References (19)

1. PC Wyer HH Osborn Recombinant tissue plasminogen activator: In my community hospital ED, will early administration of rt-PA to patients with the initial diagnosis of acute ischemic stroke reduce mortality and disability? Ann Emerg Med 30 1997 629 638
2. W Hacke M Kaste C Fieschi Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASSII) Lancet 352 1998 1245 1251
3. JM Wardlaw CP Warlow C Counsell Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke Lancet 350 1997 607 614
4. T Steiner E Bluhmki M Kaste The ECASS 3-hour cohort: Secondary analysis of ECASS data by time stratification Cerebrovasc Dis 8 1998 198 203
5. R von Kummer KL Allen R Holle Acute stroke: Usefulness of early CT findings before thrombolytic therapy Radiology 205 1997 327 333
6. W Hacke E Bluhmki T Steiner Dichotomized efficacy end points and global end-point analysis applied to the ECASS intention-to-treat data set: Post hoc analysis of ECASS I Stroke 29 1998 2073 2075
7. V Larrue R von Kurnmer G del Zoppo Hemorrhagic: transformation in acute ischemic stroke: Potential contributing factors in the European Cooperative Acute Stroke Study Stroke 28 1997 957 960
8. W Hacke M Kaste C Fieschi Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke—The European Cooperative Acute Stroke Study (ECASS) JAMA 274 1995 1017 1025
9. Generalized efficacy of t-PA for acute stroke Subgroup analysis of the NINDS t-PA Stroke Trial Stroke 28 1997 2119 2125
10. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke Stroke 28 1997 2109 2118
11. Tissue plasminogen activator for acute ischemic stroke The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group N Engl J Med 333 1995 1581 1587
12. JM Wardlaw T Yarnaguchi G del Zoppo Thrombolytic therapy versus control in acute ischaemic stroke Cochrane Library issue 1 1990 Update Software Oxford, United Kingdom
13. RJ Wityk MS Pessin RF Kaplan Serial assessment of acute stroke using the NIH Stroke Scale Stroke 25 1994 362 365
14. PC Wyer HH Osborn Recombinant tissue plasminogen activator: In my community hospital ED, will early administration of rt-PA to patients with the initial diagnosis of acute ischemic stroke reduce mortality and disability? Ann Emerg Med 30 1997 629 638
15. W Hacke M Kaste C Fieschi Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke—The European Cooperative Acute Stroke Study (ECASS) JAMA 274 1995 1017 1025
16. Tissue plasminogen activator for acute ischemic stroke The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group N Engl J Med 333 1995 1581 1587
17. W Hacke M Kaste C Fieschi Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASSII) Lancet 352 1998 1245 1251
18. W Hacke E Bluhmki T Steiner Dichotomized efficacy end points and global end-point analysis applied to the ECASS intention-to-treat data set: Post hoc analysis of ECASS I Stroke 29 1998 2073 2075
19. DB Pettiti Meta-Analysis, Decision Analysis and Cost-Effectiveness Analysis 1994 Oxford University Press New York 166 168